Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. (Q53950749)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. |
scientific article |
Statements
Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. (English)
1 reference
1 reference
Peter M Villiger
1 reference
Daniel Aeberli
1 reference
Stefan Oertle
1 reference
Heribert Mauron
1 reference
Beat Jordi
1 reference
1 July 2002
1 reference
132
1 reference
29-30
1 reference
414-422
1 reference
Identifiers
1 reference